AIM
ATYR

Alambic Investment Management’s aTyr Pharma ATYR Stock Holding History

Alambic Investment Management’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,586
Closed -$78K – 688
2017
Q1 		$78K Buy
1,586
+272
+21% +$12.4K 0.01% 612
2016
Q4 		$40K Buy
+1,314
New +$53.9K 0.01% 558
2016
Q2 		– Sell
-4,314
Closed -$238K – 590
2016
Q1 		$238K Buy
4,314
+2,933
+212% +$223K 0.08% 370
2015
Q4 		$190K Buy
+1,381
New +$196K 0.11% 288

Other funds holding ATYR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GHCM
Glen Harbor Capital Management San Diego, California $4.82B AUM 4.69% 1-Year Est. Return
MCIM
Meadow Creek Investment Management Atlanta, Georgia $5.09B AUM 5.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alambic Investment Management's ATYR Position: Q2 2017 in Review

Alambic Investment Management sold out of aTyr Pharma (ATYR) in Q2 2017, closing a stake of 1,586 shares — an estimated $78K sold.

Alambic Investment Management first reported a position in ATYR in Q4 2015 and held it in 4 quarters. The position peaked at $238K in Q1 2016. 32 funds tracked by Wall St. Rank hold ATYR as of Q2 2017.

  • Alambic Investment Management reported no remaining aTyr Pharma position as of Q2 2017 after selling out during the quarter.
  • Alambic Investment Management sold 1,586 aTyr Pharma shares in Q2 2017, an estimated $78K.
  • Alambic Investment Management first reported a position in aTyr Pharma in Q4 2015 and held it in 4 quarters.
  • Alambic Investment Management's aTyr Pharma position peaked at $238K in Q1 2016.
  • 32 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2017.

Based on Alambic Investment Management's 13F filing for Q2 2017, filed 14 Aug 2017.